Healios Company
Healios is a biotechnology company developing stem cell regenerative medicine therapies for the treatment of retinal and age-related macular diseases.
.png)
(Reupload).png)
.jpg)
Technology:
Regenerative Medicine
Industry:
Cell Therapy
Headquarters:
Tokyo, Tokyo, Japan
Founded Date:
2011
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
6
Total Funding:
$1.8M
Estimated Revenue:
$1M to $10M
Last Funding Date:
2013-10-08
Last Funding Type:
Pre-Seed
Register and Claim Ownership